AddedMD&A
On January 23, 2025, the Company entered into the Fourth Amendment to the 2021 Credit Agreement.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
all term loans under the 2021 Credit Agreement was extended to January 23, 2032, (iii) the credit spread adjustment applicable to SOFR loans under the 2021 Credit Agreement was removed, and (iv) interest rate margin applicable to all term loans under the 2021 Credit Agreement was removed.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
On December 12, 2025, the Company entered into the Fifth Amendment to the 2021 Credit Agreement.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
AddedMD&A
Pursuant to the terms of the Fifth Amendment, the Company incurred incremental term loans in an aggregate principal amount $300.0 million, which were used to fund the ASR program (Note 19).
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RemovedMD&A
Year Ended December 31, Change (dollar amounts in thousands, except share and per share data) 2024 2023 $ % Revenues $ 944,800 $ 866,378 $ 78,422 9.1% Cost of revenues, exclusive of amortization and impairment of acquired technologies 221,997 203,324 18,673 9.2% Amortization of acquired technologies 9,000 26,464 (17,464) -66.0% Impairment of acquired technologies — 431 (431) NM Cost of revenues(1) 230,997 230,219 778 0.3% Gross profit 713,803 636,159 77,644 12.2% Operating expenses: Research and development(1) 201,493 173,106 28,387 16.4% Selling and marketing(1) 142,217 140,851 1,366 1.0% General and administrative(1) 218,220 191,844 26,376 13.7% Amortization of intangible assets 71,768 71,972 (204) -0.3% Impairment of goodwill — 77,405 (77,405) NM Impairment of intangible assets — 4,906 (4,906) NM Total operating expenses 633,698 660,084 (26,386) -4.0% Operating income (loss) 80,105 (23,925) 104,030 NM Other (expense) income—net: Interest expense (64,608) (63,577) (1,031) -1.6% Interest income 12,203 16,252 (4,049) -24.9% Change in fair value of warrant liabilities 14,378 (15,096) 29,474 NM Other income—net 2,236 1,799 437 24.3% Total other (expense) income—net (35,791) (60,622) 24,831 41.0% Pretax income (loss) 44,314 (84,547) 128,861 NM Income tax provision (13,074) (5,524) (7,550) -136.7% Net income (loss) including non-controlling interest $ 31,240 $ (90,071) $ 121,311 NM Less: accretion of redeemable non-controlling interest (5,095) (2,405) (2,690) -111.9% Net income (loss) attributable to CCC Intelligent Solutions Holdings Inc.'s Common Stockholders $ 26,145 $ (92,476) $ 118,621 NM Net income (loss) per share attributable to common stockholders: Basic $ 0.04 $ (0.15) Diluted $ 0.04 $ (0.15) Weighted-average shares used in computing net income (loss) per share attributable to common stockholders: Basic 610,761,424 617,889,384 Diluted 641,875,525 617,889,384
Read it in 10-K Feb 25, 2025 at sec.govopen_in_new
RemovedMD&A
No impairment was recognized during the year ended December 31, 2024. Impairment of acquired technologies was $0.4 million for the year ended December 31, 2023 due to an impairment charge recognized as a result of lower forecasted earnings and cash flows for the Company’s China reporting unit. See Note 11 to the consolidated financial statements included elsewhere in the Annual Report on Form 10-K for additional information.
Read it in 10-K Feb 25, 2025 at sec.govopen_in_new
RemovedMD&A
There was no impairment charge recognized during the year ended December 31, 2024. We recorded impairment charges of goodwill and intangible assets of $77.4 million and $4.9 million, respectively, for the year ended December 31, 2023. The impairment charges were the result of lower forecasted earnings and cash flows for the Company’s China reporting unit. See Note 11 to the consolidated financial statements included elsewhere in this Annual Report on Form 10-K for additional information.
Read it in 10-K Feb 25, 2025 at sec.govopen_in_new
RemovedMD&A
ended December 31, 2023. The increase was due to higher variable interest rates during the year ended December 31, 2024, compared to the year ended December 31, 2023.
Read it in 10-K Feb 25, 2025 at sec.govopen_in_new
RemovedMD&A
In May 2023, the Company entered into Amendment No. 1 to the 2021 Credit Agreement (the “Amendment”) to establish SOFR as the benchmark rate for determining the applicable interest rate, replacing LIBOR. No other terms, including the amount of borrowings, required payments or maturity date, were changed as a result of the Amendment. The Company did not incur any significant costs associated with the Amendment.
Read it in 10-K Feb 25, 2025 at sec.govopen_in_new
RemovedMD&A
(1) a base rate determined by reference to the highest of (a) the rate last quoted by the Wall Street Journal as the “prime rate,” (b) the federal funds effective rate plus 0.50%, (c) one-month LIBOR plus 1.00% and (d) with respect to the Term B Loan, 1.50% and with respect to the 2021 Revolving Credit Facility, 1.00%, or
Read it in 10-K Feb 25, 2025 at sec.govopen_in_new
RemovedMD&A
We account for our Private Warrants in accordance with the guidance contained in ASC 815-40. The warrants do not meet the criteria for equity treatment, thus we classify the warrants as liabilities at their fair value and adjust the warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until the warrants are exercised or redeemed. Any change in fair value is recognized in our consolidated statements of operations and comprehensive income (loss). The fair value of the Private Warrants was determined using the Black-Scholes option pricing model.
Read it in 10-K Feb 25, 2025 at sec.govopen_in_new
RewordedMD&A
Year ended December 31, (dollar amounts in thousands) 2025 2024 2023 2022 Net income (loss) $1,688 $31,240 $(90,071) $38,406 Interest expense 71,007 64,608 63,577 38,990 Interest income (4,882) (12,203) (16,252) (908) Income tax provision 19,841 13,074 5,524 11,456 Amortization of intangible assets 74,047 71,768 71,972 72,278 Amortization of acquired technologies—Cost of revenue 17,473 9,000 26,464 26,938 Depreciation and amortization related to software, equipment and property 8,727 8,774 8,577 10,161 Depreciation and amortization related to software, equipment and property—Cost of revenue 50,033 34,134 28,325 17,772 Stock-based compensation expense and related employer payroll tax 181,285 177,808 147,707 111,865 M&A and integration costs 8,831 9,193 3,372 1,772 Litigation costs (proceeds) costs, net (3,665) 4,455 5,068 894 Equity transaction costs, including secondary offering costs 724 1,938 2,031 1,330 Change in fair value of derivative instruments 8,386 5,233 5,743 Income from derivative instruments (1,811) (7,167) (6,460) Debt refinancing costs 4,359 — — Change in fair value of contingent consideration — (100) — (100) Change in fair value of warrant liabilities — (14,378) 15,096 (26,073) Change in fair value of derivative instruments 5,233 5,743 (5,663) Income from derivative instruments (7,167) (6,460) — Goodwill and intangible asset impairment charges — — 82,742 — Lease abandonment — — 6,137 Contract termination costs — — 3,248 Lease overlap costs — — 1,338 Gain on sale of cost method investment — — (3,587) Income related to divestiture, net — — (877) Adjusted EBITDA $436,043 $397,377 $353,415 $305,377 Adjusted EBITDA Margin 41% 42% 41% 39%
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
Year ended December 31, (dollar amounts in thousands) 2025 2024 2023 2022 Net income (loss) $ 1,688 $ 31,240 $ (90,071) $ 38,406 Amortization of intangible assets 74,047 71,768 71,972 72,278 Amortization of acquired technologies—Cost of revenue 17,473 9,000 26,464 26,938 Stock-based compensation expense and related employer payroll tax 181,285 177,808 147,707 111,865 M&A and integration costs 8,831 9,193 3,372 1,772 Litigation costs (proceeds) costs, net (3,665) 4,455 5,068 894 Equity transaction costs, including secondary offering costs 724 1,938 2,031 1,330 Change in fair value of derivative instruments 8,386 5,233 5,743 Debt refinancing costs 4,359 — — Change in fair value of contingent consideration — (100) — (100) Change in fair value of warrant liabilities — (14,378) 15,096 (26,073) Change in fair value of derivative instruments 5,233 5,743 (5,663) Goodwill and intangible asset impairment charges — — 82,742 — Lease abandonment — — 6,137 Contract termination costs — — 3,248 Lease overlap costs — — 1,338 Gain on sale of cost method investment — — (3,587) Income related to divestiture, net — — (877) Tax effect of adjustments (55,105) (58,086) (59,638) (51,495) Adjusted net income $ 238,023 $ 238,071 $ 210,486 $ 176,411 Adjusted net income per share attributable to common stockholders Basic $ 0.38 $ 0.39 $ 0.34 Diluted $ 0.29 Diluted 0.36 $ 0.37 $ 0.32 $ 0.27 Weighted average shares outstanding Basic 629,960,378 610,761,424 617,889,384 607,760,886 Diluted 659,585,375 641,875,525 651,587,360 642,841,596
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
Adjusted EBITDA is defined as net income (loss) adjusted for interest, taxes, amortization, depreciation, stock-based compensation expense and related employer payroll tax, costs associated with the acquisition and integration of completed and potential M&A, litigation (proceeds) costs, net and costs in legal matters in which we are the plaintiff and related antitrust matters, equity transaction and related costs, including secondary offering costs, change in fair value of derivative instruments, income from derivative instruments, debt refinancing costs, change in fair value of contingent consideration, change in fair value of warrant liabilities, change in fair value of derivative instruments, income from derivative instruments, goodwill and intangible asset impairment charges, lease abandonment charges, contract termination costs, lease overlap costs for the incremental expenses associated with the Company’s new corporate headquarters prior to termination of its then existing headquarters’ lease, gain on sale of cost method investment and income related to divestiture, net. charges.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
Adjusted Operating Expenses is defined as operating expenses adjusted for amortization of intangible assets, stock-based compensation expense and related employer payroll tax, costs associated with the acquisition and integration of completed and potential mergers and acquisitions (“M&A”), litigation costs in legal matters in which we are the plaintiff and related antitrust matters, equity transaction and related costs, including secondary offering costs, change in fair value of contingent consideration, goodwill and intangible asset impairment charges, lease abandonment charges, lease overlap costs for the incremental expenses associated with the Company’s new corporate headquarters prior to termination of its then existing headquarters’ lease and income related to divestiture, net. proceeds (costs), net
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
Year ended December 31, (dollar amounts in thousands) 2025 2024 2023 2022 Operating income (loss) $80,105 $(23,925) $51,922 $ 93,842 $ 80,105 $ (23,925) Amortization of intangible assets 74,047 71,768 71,972 72,278 Amortization of acquired technologies—Cost of revenue 17,473 9,000 26,464 26,938 Stock-based compensation expense and related employer 181,285 177,808 147,707 111,865 payroll tax M&A and integration costs 8,831 9,193 3,372 1,772 Litigation costs (proceeds) costs, net (3,665) 4,455 5,068 894 Equity transaction costs, including secondary offering costs 724 1,938 2,031 1,330 Debt refinancing costs 4,359 — — Change in fair value of contingent consideration — (100) — (100) Goodwill and intangible asset impairment charges — — 82,742 — Lease abandonment — — 6,137 Contract termination costs — — 3,248 Lease overlap costs — — 1,338 Income related to divestiture, net — — (877) Adjusted operating income $354,167 $315,431 $276,745 $ 376,896 $ 354,167 $ 315,431
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
Adjusted Net Income is defined as net income (loss) adjusted for the after-tax effects of amortization, stock-based compensation expense and related employer payroll tax, costs associated with the acquisition and integration of completed and potential M&A, litigation (proceeds) costs, net and costs in legal matters in which we are the plaintiff and related antitrust matters, equity transaction and related costs, including secondary offering costs, change in fair value of derivative instruments, debt refinancing costs change in fair value of contingent consideration, change in fair value of warrant liabilities, change in fair value of derivative instruments, liabilities and goodwill and intangible asset impairment charges. lease abandonment charges, contract termination costs, lease overlap costs for the incremental expenses associated with the Company’s new corporate headquarters prior to termination of its then existing headquarters’ lease, gain on sale of cost method investment and income related to divestiture, net.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
Year ended December 31, (dollar amounts in thousands) 2025 2024 2023 2022 Operating expenses $ 682,966 $ 633,698 $ 660,084 $ 516,587 Amortization of intangible assets (74,047) (71,768) (71,972) (72,278) Stock-based compensation expense and related (169,686) (167,865) (138,578) (105,775) employer payroll tax M&A and integration costs (8,831) (9,193) (3,372) (1,772) Litigation costs proceeds (costs), net 3,665 (4,455) (5,068) (894) Equity transaction costs, including secondary offering costs (724) (1,938) (2,031) (1,330) Debt refinancing costs (4,359) — — Change in fair value of contingent consideration — 100 — 100 Goodwill and intangible asset impairment charges — — (82,311) — Lease abandonment — — (6,137) Lease overlap costs — — (1,338) Income related to divestiture, net — — 877 Adjusted operating expenses $ 428,984 $ 378,579 $ 356,752 $ 328,040
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
Adjusted Operating Income is defined as operating income (loss) adjusted for amortization, stock-based compensation expense and related employer payroll tax, costs associated with the acquisition and integration of completed and potential M&A, litigation (proceeds) costs, net and costs in legal matters in which we are the plaintiff and related antitrust matters, equity transaction and related costs, including secondary offering costs, debt refinancing costs, change in fair value of contingent consideration, consideration and goodwill and intangible asset impairment charges, lease abandonment charges, contract termination costs, lease overlap costs for the incremental expenses associated with the Company’s new corporate headquarters prior to termination of its then existing headquarters’ lease and income related to divestiture, net. charges.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
Pursuant to the terms of the Fourth Amendment, (i) the Company incurred incremental term loans in an aggregate principal amount of $225 $225.0 million, which were used to (i) refinance certain outstanding incremental term loans (including the Incremental Term Loan), Loans), (ii) extend the maturity of all term loans to January 23, 2032, (iii) remove the credit spread adjustment applicable to SOFR loans, and (iv) reduce the interest rate margin applicable to all term loans to the following rate:
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
The increase was primarily due to a $21.7 $46.1 million increase in personnel-related costs, including a $9.9 million increase in stock-based compensation, primarily due to the acquisition of EvolutionIQ in January 2025, partially offset by a $6.2 $10.0 million increase decrease in IT related costs, and a $3.3 $9.2 million decrease increase in the amount of capitalized time on new and enhanced customer solutions and platform development, partially offset by and a $1.9 $0.8 million decrease in consulting and professional service costs.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
Pursuant to the terms of the Fourth Amendment, (i) the Company incurred incremental term loans in an aggregate principal amount of $225 million, which were used to (i) refinance certain outstanding incremental term loans (including the Incremental Term Loan), (ii) extend the maturity of all term loans under the 2021 Credit Agreement was extended to January 23, 2032, (iii) remove the credit spread adjustment applicable to SOFR loans, Secured Overnight Financing Rate (“SOFR”) loans under the 2021 Credit Agreement was removed, and (iv) reduce the interest rate margin applicable to all term loans to under the following rate: 2021 Credit Agreement was removed.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
RewordedMD&A
Other than the business acquisition discussed in the “Recent Developments” section of this Management’s Discussion and Analysis of Financial Condition and Results of Operations, which has closed and for which payment has been completed, we We are not currently a party to any material definitive agreement regarding potential investments in, or acquisitions of, complementary business, applications or technologies.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new
Quiet changesMD&A
The income tax provision for the year ended December 31, 2024 was primarily due to the Company’s pretax income.
Read it in 10-K Feb 24, 2026 at sec.govopen_in_new